Shandong Xinhua Pharmaceutical Company Limited Cash Flow Reinvestment Rate
Shandong Xinhua Pharmaceutical Company Limited cash flow reinvestment rate. Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow Reinvestment Rate of 2.64x as of September 2023, reinvesting €148.38 Million (capex €80.69 Million plus investments €-67.69 Million) from operating cash flow of €56.11 Million. See financial flexibility index of Shandong Xinhua Pharmaceutical Company L to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Cash flow reinvestment rate of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. Historical reinvestment intensity for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Explore XIN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Shandong Xinhua Pharmaceutical Company Limited Cash Flow Reinvestment Rate by Year (2013–2025)
Shandong Xinhua Pharmaceutical Company Limited cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for Shandong Xinhua Pharmaceutical Company Limited. For the full cash flow conversion analysis, see XIN cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | €125.40 Million | €533.73 Million | €115.60 Million | ▼ -60.8% |
| 2024 | 0.60x | €220.60 Million | €367.61 Million | €212.42 Million | ▼ -74.7% |
| 2023 | 2.38x | €630.24 Million | €265.28 Million | €325.13 Million | ▲ +280.3% |
| 2022 | 0.62x | €473.66 Million | €758.24 Million | €244.76 Million | ▼ -66.8% |
| 2021 | 1.88x | €486.92 Million | €259.12 Million | €249.23 Million | ▲ +154.6% |
| 2020 | 0.74x | €310.19 Million | €420.19 Million | €280.19 Million | ▼ -39.3% |
| 2019 | 1.22x | €423.28 Million | €348.27 Million | €366.51 Million | ▼ -11.6% |
| 2018 | 1.37x | €445.21 Million | €323.91 Million | €388.44 Million | ▲ +82.1% |
| 2017 | 0.75x | €294.31 Million | €389.97 Million | €261.11 Million | ▼ -29.5% |
| 2016 | 1.07x | €470.36 Million | €439.35 Million | €227.07 Million | ▲ +97.0% |
| 2015 | 0.54x | €189.42 Million | €348.64 Million | €169.09 Million | ▼ -32.4% |
| 2014 | 0.80x | €278.23 Million | €346.34 Million | €260.17 Million | ▼ -76.7% |
| 2013 | 3.45x | €362.58 Million | €104.99 Million | €344.53 Million | — |